SEARLE & CO. - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 200 filers reported holding HERON THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.

Quarter-by-quarter ownership
SEARLE & CO. ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$87,808
-32.4%
85,250
+8.9%
0.03%
-25.0%
Q2 2023$129,895
-14.1%
78,250
+23.7%
0.04%
-18.4%
Q1 2023$151,168
+81.9%
63,250
+90.2%
0.05%
+75.0%
Q4 2022$83,125
-40.6%
33,2500.0%0.03%
-48.1%
Q3 2022$140,000
+50.5%
33,2500.0%0.05%
+45.9%
Q2 2022$93,000
-51.1%
33,2500.0%0.04%
-47.1%
Q1 2022$190,000
-56.4%
33,250
-30.4%
0.07%
-56.0%
Q4 2021$436,000
-14.5%
47,7500.0%0.16%
-23.9%
Q3 2021$510,000
-30.4%
47,750
+1.1%
0.21%
-30.3%
Q2 2021$733,000
+21.4%
47,250
+26.8%
0.30%
+11.5%
Q1 2021$604,000
-24.4%
37,250
-1.3%
0.27%
-29.9%
Q4 2020$799,000
+39.9%
37,750
-1.9%
0.38%
+23.5%
Q3 2020$571,000
+33.7%
38,500
+32.8%
0.31%
+25.4%
Q2 2020$427,000
+23.4%
29,000
-1.7%
0.25%
+1.2%
Q1 2020$346,000
+17.7%
29,500
+136.0%
0.24%
+51.2%
Q4 2019$294,000
+44.1%
12,500
+13.6%
0.16%
+35.0%
Q3 2019$204,000
-48.1%
11,000
-48.0%
0.12%
-49.8%
Q2 2019$393,000
+7.1%
21,150
-20.2%
0.24%
-5.2%
Q2 2017$367,000
+4.0%
26,500
+12.8%
0.25%
+1.6%
Q1 2017$353,00023,5000.25%
Other shareholders
HERON THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
TANG KEVIN C 21,288$250,00019.87%
TANG CAPITAL MANAGEMENT LLC 2,896,904$34,010,0004.78%
PFM Health Sciences, LP 2,481,917$29,138,0002.39%
Iron Triangle Partners LP 500,000$5,870,0002.27%
NEXPOINT ASSET MANAGEMENT, L.P. 777,599$9,129,0001.72%
Pekin Hardy Strauss, Inc. 588,732$6,912,0001.55%
First Light Asset Management, LLC 691,400$8,117,0001.39%
Congress Park Capital LLC 111,045$1,304,0001.18%
Mesirow Financial Investment Management, Inc. 15,135$178,0001.12%
Elk Creek Partners, LLC 509,174$5,978,0001.03%
View complete list of HERON THERAPEUTICS INC shareholders